Pfizer Inc. (PFE) Financial Statements
Pfizer Inc. (PFE) reported trailing twelve-month revenue of $63.7B (down 0.2% year on year) and net income of $4.3B as of 2026-06-30, according to EquiReason's reading of its SEC filings. Free cash flow over the same period: $11.0B.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
PFEPfizer Inc.Follow PFE — free
—
Price chart with a free account
- Market cap
- 171.2B
- P/E TTM
- 39.5
- Dividend yield
- 5.7%
- 52-week
- —
- Next earnings
- 3 Nov, in 10 days
Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jun 26.
| Line | FY2009 Dec 09 | FY2010 Dec 10 | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 49.27 | 65.17 | 61.04 | 54.66 | 51.58 | 40.83 | 40.91 | 41.65 | 73.64 | 101.18 | 59.55 | 63.63 | 62.58 | 63.70 | |
| Gross profit | 40.81 | 50.38 | 48.54 | 44.84 | — | 31.84 | 32.85 | 33.17 | 42.82 | 66.83 | 34.60 | 45.78 | 46.51 | 46.61 | |
| Research & development | 7.82 | 9.48 | 8.68 | 7.48 | 6.68 | 7.76 | 8.39 | 8.71 | 10.36 | 11.43 | 10.68 | 10.82 | 10.44 | 11.05 | |
| Pre-tax income | 10.67 | 9.47 | 11.48 | 11.24 | 15.72 | 3.59 | 11.32 | 7.04 | 24.31 | 34.73 | 1.06 | 8.02 | 7.52 | 4.21 | |
| Income tax | 2.15 | 1.15 | 3.62 | 2.22 | 4.31 | -0.27 | 0.58 | 0.37 | 1.85 | 3.33 | -1.12 | -0.03 | -0.27 | -0.16 | |
| Net income | 8.64 | 8.26 | 10.01 | 14.57 | 22.00 | 11.15 | 16.03 | 9.16 | 21.98 | 31.37 | 2.12 | 8.03 | 7.77 | 4.33 | |
| Diluted EPS ($) | 1.23 | 1.02 | 1.27 | 1.94 | 3.19 | 1.87 | 2.82 | 1.63 | 3.85 | 5.47 | 0.37 | 1.41 | 1.36 | 0.76 | |
| Diluted shares (bn) | 7.045 | 8.074 | 7.870 | 7.508 | 6.895 | 5.977 | 5.675 | 5.632 | 5.708 | 5.733 | 5.709 | 5.700 | 5.713 | — |
USD billions · SEC XBRL
Pfizer Inc. — questions
- What is Pfizer Inc.'s revenue?
- $63.7B over the twelve months to 2026-06-30, down 0.2% year on year, from its 10-Q and 10-K filings.
- What is Pfizer Inc.'s net income?
- $4.3B over the twelve months to 2026-06-30.
- What is Pfizer Inc.'s free cash flow?
- $11.0B over the twelve months to 2026-06-30.
- What are Pfizer Inc.'s diluted earnings per share?
- $0.76 over the twelve months to 2026-06-30.
Every figure on this page comes from Pfizer Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.